- Home
- TFIN vs NVAX Comparison
TFIN vs NVAX Comparison
Compare TFIN & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TFIN
- NVAX
- Stock Information
- Founded
- TFIN 1981
- NVAX 1987
- Country
- TFIN United States
- NVAX United States
- Employees
- TFIN N/A
- NVAX N/A
- Industry
- TFIN Major Banks
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TFIN Finance
- NVAX Health Care
- Exchange
- TFIN Nasdaq
- NVAX Nasdaq
- Market Cap
- TFIN 1.2B
- NVAX 1.3B
- IPO Year
- TFIN N/A
- NVAX 1995
- Fundamental
- Price
- TFIN $48.39
- NVAX $9.23
- Analyst Decision
- TFIN Hold
- NVAX Buy
- Analyst Count
- TFIN 4
- NVAX 7
- Target Price
- TFIN $70.75
- NVAX $14.29
- AVG Volume (30 Days)
- TFIN 224.7K
- NVAX 4.4M
- Earning Date
- TFIN 10-15-2025
- NVAX 11-11-2025
- Dividend Yield
- TFIN N/A
- NVAX N/A
- EPS Growth
- TFIN N/A
- NVAX N/A
- EPS
- TFIN 0.44
- NVAX 2.54
- Revenue
- TFIN $409,227,000.00
- NVAX $1,078,718,000.00
- Revenue This Year
- TFIN $12.07
- NVAX $60.81
- Revenue Next Year
- TFIN $14.74
- NVAX N/A
- P/E Ratio
- TFIN $109.67
- NVAX $3.62
- Revenue Growth
- TFIN 2.49
- NVAX 9.22
- 52 Week Low
- TFIN $42.90
- NVAX $5.01
- 52 Week High
- TFIN $110.58
- NVAX $13.77
- Technical
- Relative Strength Index (RSI)
- TFIN 30.94
- NVAX 60.85
- Support Level
- TFIN $47.41
- NVAX $8.32
- Resistance Level
- TFIN $50.43
- NVAX $9.05
- Average True Range (ATR)
- TFIN 2.01
- NVAX 0.41
- MACD
- TFIN -0.68
- NVAX 0.06
- Stochastic Oscillator
- TFIN 7.58
- NVAX 68.06
About TFIN Triumph Financial Inc.
Triumph Financial Inc is a financial holding company. The company has four reportable segments namely Banking, Factoring, Payments, and Intelligence. The Banking segment includes the operations of TBK Bank. The Factoring segment includes the operations of Triumph Financial Services with revenue derived from factoring services, The Payments segment includes the operations of TBK Bank's TriumphPay division which provides a presentment, audit and payment solution to Shipper, Broker, and Factor clients in the trucking industry and The Intelligence segment includes to turn the over-the-road trucking data collected through the services into actionable insights for their customers.
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.